C0034802||EGFR
C0069515||HER2
C0006142||breast cancer
C0007608||cell motility
C0287920||signal transducer and activator of transcription 1
C2716282||ACTA2
C0034802||EGFR
C0069515||HER2
C0033325||prognosis
C2699153||cell invasion
C0034802||EGFR
C0006142||breast cancer
C1171362||expressions
C2716282||alpha-smooth muscle actin
C2716282||ACTA2
C0287920||signal transducer and activator of transcription 1
C0287920||signal transducer and activator of transcription 1
C1514559||overexpression
C0069515||HER2
C0034802||EGFR
C1446409||positive
C0006142||breast cancer
C0007634||cells
C2716282||ACTA2
C0287920||signal transducer and activator of transcription 1
C1171362||expression
C0069515||HER2
C1446409||positive
C0006142||breast cancer
C2716282||ACTA2
C1171362||expression
C1099354||HER2 siRNA
C0287920||signal transducer and activator of transcription 1
C2716282||ACTA2
C1171362||expression
C2716282||ACTA2
C1171362||expression
C0087111||treatment
C1254351||STAT1 inhibitor
C0059985||fludarabine
C1254351||JAK2 inhibitor
C0381241||AG490
C2716282||ACTA2
C1171362||expression
C0287920||signal transducer and activator of transcription 1
C1514559||overexpression
C2716282||ACTA2
C0287920||signal transducer and activator of transcription 1
C0069515||HER2
C0332167||high-risk
C0006142||breast cancer
C2716282||ACTA2
C0007608||cell motility
C2930586||ACTA2 shRNA
C1514559||overexpression
C1512505||MDA-MB231
C0069515||HER2
C1512505||4T1 mammary carcinoma cells
C0034079||lung metastatic nodules
C2716282||ACTA2
C0206745||knockdown mice
C2716282||ACTA2
C0034802||EGFR
C0069515||HER2
C0169661||JAK2
C0287920||signal transducer and activator of transcription 1
C0037080||signaling pathway
C2716282||ACTA2
C1171362||expression
C0027626||invasiveness
C0027627||metastasis
C0006142||breast cancer
C0007634||cells